Suppr超能文献

肾细胞癌中c-KIT(CD117)表达的免疫组织化学研究

Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.

作者信息

Ahmed Eman Abdelzaher, Youssif Mohammed Elsayed

机构信息

The Department of Pathology, Alexandria University, Alexandria, Egypt.

出版信息

J Egypt Natl Canc Inst. 2009 Jun;21(2):121-32.

Abstract

OBJECTIVE

Certain subtypes of Renal cell carcinomas (RCCs) are diagnostically challenging owing to their overlapping histopathological features. Recently, c-KIT (CD117) has come into focus as a potential diagnostic marker of some renal tumors. c-KIT also provides a potentially suitable for targeted tumor therapy. The present study was designed to investigate the expression of c-KIT in RCCs in order to evaluate its diagnostic usefulness as a phenotypic marker and to establish the basis for a new possible therapeutic modality.

MATERIAL AND METHODS

The present work was conducted on 49 patients with RCC: Clear cell RCC (CRCC): 30 cases (61.22%); chromophobe RCC (ChRCC): 9 cases (18.37%); papillary RCC (PRCC), type I: 5 cases (10.20%); and carcinoma of the collecting ducts of Bellini (CdRCC): 5 cases (10.20%). The expression of c-KIT was assessed using immunohistochemistry. The diagnostic performance of c-KIT expression was evaluated using ROC curve analysis.

RESULTS

Overall, 11 (22.5%) cases of RCC showed c-KIT expression: 2 (6.7%) CRCC, 7 (77.8%) ChRCC, and 2 (40.0%) CdRCC. Among the study group, ChRCC had the highest frequency (p=.001) and staining score (p=.001) for c-KIT. In addition, only ChRCC showed membranous pattern of c-KIT staining, while other tumors showed cytoplasmic staining (p=.013). c-KIT showed a sensitivity of 77.78%and a specificity of 95%for the diagnosis of ChRCC. The relation between c-KIT expression and clinicopathological parameters was not significant. High grade tumors had a statistically significant higher total score of c-KIT expression (p=.023).

CONCLUSIONS

c-KIT is frequently and significantly expressed in chromophobe RCC suggesting that it might play a role in its pathogenesis. Immunohistochemical detection of c-KIT expression could be used to aid histological diagnosis of chromophobe RCC with a high sensitivity and specificity. The substantial c-Kit immunoreactivity in chromophobe RCC may be of clinical importance especially in the field of targeted therapy.

摘要

目的

某些肾细胞癌(RCC)亚型因其组织病理学特征重叠而在诊断上具有挑战性。最近,c-KIT(CD117)作为一些肾肿瘤的潜在诊断标志物受到关注。c-KIT也为靶向肿瘤治疗提供了一种潜在的适用方法。本研究旨在调查c-KIT在RCC中的表达,以评估其作为表型标志物的诊断效用,并为一种新的可能治疗方式奠定基础。

材料与方法

本研究对49例RCC患者进行:透明细胞RCC(CRCC):30例(61.22%);嫌色细胞RCC(ChRCC):9例(18.37%);I型乳头状RCC(PRCC):5例(10.20%);以及Bellini集合管癌(CdRCC):5例(10.20%)。使用免疫组织化学评估c-KIT的表达。使用ROC曲线分析评估c-KIT表达的诊断性能。

结果

总体而言,11例(22.5%)RCC病例显示c-KIT表达:2例(6.7%)CRCC,7例(77.8%)ChRCC,以及2例(40.0%)CdRCC。在研究组中,ChRCC的c-KIT频率(p = 0.001)和染色评分(p = 0.001)最高。此外,只有ChRCC显示c-KIT染色的膜状模式,而其他肿瘤显示细胞质染色(p = 0.013)。c-KIT对ChRCC诊断的敏感性为77.78%,特异性为95%。c-KIT表达与临床病理参数之间的关系不显著。高级别肿瘤的c-KIT表达总分在统计学上显著更高(p = 0.023)。

结论

c-KIT在嫌色细胞RCC中频繁且显著表达,表明它可能在其发病机制中起作用。c-KIT表达的免疫组织化学检测可用于辅助嫌色细胞RCC的组织学诊断,具有高敏感性和特异性。嫌色细胞RCC中大量的c-Kit免疫反应性可能具有临床重要性,尤其是在靶向治疗领域。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验